Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Malaria Mass Drug Administration on Malaria Prevalence
NCT07358767Completed
- Sponsor
- Noguchi Memorial Institute for Medical Research
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artemether + lumefantrine in malaria (2 arms), sponsored by Noguchi Memorial Institute for Medical Research. Primary endpoint: Prevalence of malaria asymptomatic parasitaemia. Started Jul 2021; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07358767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07358767.